SAN DIEGO, Nov. 15, 2018 /PRNewswire/ -- NuVasive, Inc.
BH, ENLK, R, DVN and NUVA were all recently downgraded by TheStreet’s Quant Ratings service.
Company receives FDA 510(k) clearance for use of COHERE® interbody in XLIF® procedure as new clinical study further validates important benefits of Porous PEEK™ material technology
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BXMT, CHK, CHMI, CWEN, CWEN.A, EBMT, EFC, HASI, HIIQ, HMST, HTBI, HY, HZNP, JTPY, KNDI, LARK, LMRK, MBI, MFNC, MFSF, PBFX, RC, TEUM, UBNK, URG Downgrades: APTV, CFBK, CNFR, CPLP, CVEO, HF, HNGR, HPJ, IAG, INS, LGL, MAA, MCRN, MDRX, MHH, MTLS, NFBK, NUVA, OFED, OMI, VTSI, WNC, WSTL Initiations: I, ONS Read on to get TheStreet Quant Ratings' detailed report:
SAN DIEGO, Oct. 30, 2018 /PRNewswire/ -- NuVasive, Inc.
SAN DIEGO, Oct. 19, 2018 /PRNewswire/ -- NuVasive, Inc.
SAN DIEGO, Oct. 11, 2018 /PRNewswire/ -- NuVasive, Inc.
Biedermann Technologies' leading innovations to be available with NuVasive's RELINE® posterior fixation system to create differentiated adult and pediatric technology solutions
SAN DIEGO, Oct. 8, 2018 /PRNewswire/ -- NuVasive, Inc.
New technologies launched to expand deformity portfolio to address additional pediatric and adult patients' clinical needs
SAN DIEGO, Sept. 26, 2018 /PRNewswire/ -- NuVasive, Inc.
Initial Pulse Alpha Trial Results Show Extensive Clinical Utility in Nearly all Spine Surgery Cases and Workflow Efficiencies Intended to Reduce Operating Room Time for Surgeon and Patient
SAN DIEGO, Sept. 24, 2018 /PRNewswire/ -- NuVasive, Inc.
New board appointment brings expertise in surgical robotics, data analytics and medical device commercialization
SAN DIEGO, Sept. 20, 2018 /PRNewswire/ -- NuVasive, Inc.
SAN DIEGO, Sept. 11, 2018 /PRNewswire/ -- NuVasive, Inc.
SAN DIEGO, Sept. 6, 2018 /PRNewswire/ -- NuVasive, Inc.
SAN DIEGO, Sept. 5, 2018 /PRNewswire/ -- NuVasive, Inc.
SAN DIEGO, Sept. 4, 2018 /PRNewswire/ -- NuVasive, Inc.
GE Healthcare veteran joins NuVasive to further its goal of operational excellence
Spine Precision Partnership™ to advance clinical outcomes in spine procedures through the novel integration of 3D imaging, navigation and surgical automation
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: CHEF, CLH, DYSL, FLR, FORM, GPOR, HI, IBM, KBR, KW, NUVA, TGE, WSTL, X Downgrades: EMKR, PSMT, SEB Initiations: APPN, APRN, GDI Read on to get TheStreet Quant Ratings' detailed report:
SAN DIEGO, July 31, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced financial results for...
Pulse™ platform receives 510(k) clearance addressing spine technology and clinical requirements across all spine procedures
The latest advancement of MAGEC® delivers improved rod strength together with internal rod mechanism advancements
The launch of Reline® MAS® Midline delivers procedural versatility in a compact midline construct
SAN DIEGO, July 11, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the Company will release...
XLX™ ACR® receives FDA 510(k) clearance and broadens expandable portfolio to include lateral procedures
